Clinical Trials Logo

Locally Advanced Cancer clinical trials

View clinical trials related to Locally Advanced Cancer.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03119428 Terminated - Metastatic Cancer Clinical Trials

A Study of OMP-313M32 in Subjects With Locally Advanced or Metastatic Solid Tumors

Start date: May 2, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and tolerability of OMP-31M32 as a single agent or in combination with nivolumab. OMP-313M32 is an experimental anti-TIGIT antibody that was developed to block TIGIT from binding PVR allowing the body's T-cells to destroy cancer cells.